Global Mycoplasma Testing Market 2025–2029: Unveiling Growth Developments with the Latest Updates
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Much Will The Mycoplasma Testing Market Be Worth By 2029?
The market size of mycoplasma testing has seen rapid expansion in the past few years. It is projected to increase from a value of $1.08 billion in 2024 to about $1.23 billion in 2025 with a compound annual growth rate (CAGR) of 13.3%. Factors contributing to this growth in the historic period include outbreak and contamination incidents, increased awareness, progress in the biotechnological field, initiatives in research and development, trends in the healthcare industry, and upsurge in cell culture production.
The market for mycoplasma testing is poised for swift expansion in the forthcoming years. It is predicted to rise to $1.9 billion by 2029, with a compound annual growth rate (CAGR) of 11.6%. The escalating demand for quality assurance, growth in the biopharmaceutical sector, upswing in cell-based treatments, and the enlargement of the biotechnology industry can be credited for the enlargement in the forecast period. Key trends during this period are expected to be regulatory standards and compliance, increased awareness in healthcare and diagnostics, readiness for global pandemics, cutting-edge point-of-care testing, and gaining a foothold in developing economies.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4103&type=smp
What Market Forces Are Contributing To The Growth Of The Mycoplasma Testing Market?
The rise in incidences of mycoplasma pneumonia is anticipated to stimulate the expansion of the mycoplasma testing market. Mycoplasma pneumonia, a respiratory infection instigated by the bacteria Mycoplasma pneumoniae, is often diagnosed through mycoplasma testing. These tests detect the Mycoplasma pneumoniae bacteria in respiratory samples, facilitating the prompt and correct detection of the infection, allowing for optimal medical care and management. For instance, the Centers for Disease Control and Prevention, a US government agency, reported an estimated 2 million cases of Mycoplasma pneumoniae infections annually in the United States as of December 2023. Hence, the growing prevalence of mycoplasma pneumonia is contributing significantly to the growth of the mycoplasma testing market.
Which Segments Define The Structure Of The Mycoplasma Testing Market?
The mycoplasma testingmarket covered in this report is segmented –
1) By Product: Instruments; Assay, Kits, and Reagents
2) By Technology: PCR; ELISA; Enzymatic Methods; DNA Staining; Other Technologies
3) By Application: Cell line Testing; Virus Testing; End- of- Production Cell Testing
4) By End User: Pharmaceutical & Biotechnology Companies; Cell Banks & Laboratories; Contract Research Organizations; Academic Research Institutes
Subsegments:
1) By Instruments: Mycoplasma Detection Systems; Automated Test Equipment; PCR Equipment
2) By Assay: Mycoplasma Assays (PCR-Based, Culture-Based); Qualitative Assays; Quantitative Assays
3) By Kits: Mycoplasma Detection Kits; Mycoplasma Testing Kits for Cell Cultures; Sample Preparation Kits
4) By Reagents: Nucleic Acid Reagents; Cell Culture Reagents; Staining Reagents
Which Disruptive Trends Are Driving Change Across The Mycoplasma Testing Market?
Primary operators in the mycoplasma testing market are leveraging strategic investments like the introduction of ground-breaking products, R&D enhancements, and tech innovations, contributing substantially to the market’s prestige. In the face of a competitive commercial environment, these companies are rolling out inventive products that align with end-users’ needs and broaden their customer base. For instance, SwiftDx, a biotech firm based in the UK, initiated a new detection test for mycoplasma contamination in October 2022 using a PCR-based method. The SwiftDx Mycoplasma Detection Kit, a lateral flow test, provides a speedy and precise detection of mycoplasma, drawing a small sample directly from cell culture media supernatant without disrupting cell growth. The results are provided in a straightforward and easy-to-interpret format. The test boasts of high sensitivity and specificity, detecting less than 10 cfu/mL after the 3rd day of culture.
Which Firms Are Making The Biggest Impact In The Mycoplasma Testing Market?
Major companies operating in the mycoplasma testing market include Abbott Laboratories, Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Roche Diagnostics International AG, Charles River Laboratories International Inc., Nelson Laboratories Fairfield Inc., Creative Bioarray, Biological Industries Israel Beit Haemek Ltd., Biotools B & M Labs S.A, PromoCell GmbH, American Type Culture Collection, Bionique Testing Laboratories Inc., InvivoGen, Clongen Laboratories LLC, Norgen Biotek Corporation, Gen Bio Sciences (P) Ltd., GeneCopoeia Inc., Minerva Biolabs GmbH, Mycoplasma Experience, Savyon Diagnostics, ScienCell Research Laboratories Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report
Which Region Is Forecasted To Lead The Mycoplasma Testing Market In The Coming Years?
North America was the largest region in the mycoplasma testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the mycoplasma testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=4103&type=smp
Browse Through More Reports Similar to the Global Mycoplasma Testing Market 2025, By The Business Research Company
Healthcare Analytical Testing Services Global Market Report 2025
Automotive Testing Inspection And Certification Global Market Report 2025
Cold Plasma Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
